Autologous Stem Cell Transplantation in Chronic Lymphocytic Leukemia

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2009
Phase III trial evaluating the role of autologous stem cell transplantation in previously untreated patients under 65 years with stage B and C B-cell chronic lymphocytic leukemia. Endpoints of the trial : * major : progression free survival at 3 years * secondary : overall survival, tolerance, prognostic factors according to baseline clinical stage and biological characteristics (IgHv mutational status, expression of ZAP70 and CD38, cytogenetics).
Epistemonikos ID: 027ef65008140260ea07e8d6df3cc42f1e1f64ac
First added on: Jan 21, 2022